MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Balance Sheets Overview

Current Ratio
535.63%
Quick Ratio
535.63%
Cash Ratio
183.07%
Debt to Asset Ratio
24.86%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Property and equipment, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, non...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
72,985
90,770
60,181
123,575
Marketable securities
131,117
163,253
187,039
196,049
Prepaid expenses and other current assets
9,439
13,281
13,719
8,577
Total current assets
213,541
267,304
260,939
328,201
Restricted cash
1,587
1,586
1,585
1,585
Marketable securities, non-current
23,896
6,954
0
0
Other investments
19,000
19,000
19,000
19,000
Property and equipment, net
30,507
32,720
34,771
36,722
Operating lease right-of-use assets
16,781
17,828
18,871
19,912
Other non-current assets
5,841
5,234
4,886
2,545
Total assets
311,153
350,626
340,052
407,965
Accounts payable
3,879
5,468
2,893
2,568
Accrued liabilities and other current liabilities
35,988
31,479
46,519
29,310
Contingent consideration payable
-
-
0
0
Total current liabilities
39,867
36,947
49,412
31,878
Operating lease liabilities, non-current
36,934
39,487
41,921
44,285
Other non-current liabilities
537
527
517
2,681
Total liabilities
77,338
76,961
91,850
78,844
Common stock, 0.0001 par value 500,000 shares authorized at june30, 2026 and december31, 2025 23,397 and 21,251 shares issued and outstanding at june30, 2026 and december31, 2025, respectively
2
2
2
2
Additional paid-in capital
1,922,433
1,917,379
1,867,512
1,807,749
Accumulated other comprehensive (loss) income
-158
-9
242
201
Accumulated deficit
-1,688,462
-1,643,707
-1,619,554
-1,478,831
Total stockholders equity
233,815
273,665
248,202
329,121
Total liabilities and stockholders equity
311,153
350,626
340,052
407,965
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

LYEL Balance Sheet Sankey DiagramSankey diagram visualizing LYEL balance sheet for the periodMarketable securities$131,117K (-26.33%↓ Y/Y)Cash and cashequivalents$72,985K (-26.13%↓ Y/Y)Prepaid expenses andother current assets$9,439K (74.02%↑ Y/Y)Total current assets$213,541K (-24.33%↓ Y/Y)Property and equipment,net$30,507K (-22.01%↓ Y/Y)Marketable securities,non-current$23,896K (19.13%↑ Y/Y)Other investments$19,000K (0.00%↑ Y/Y)Operating leaseright-of-use assets$16,781K (-19.90%↓ Y/Y)Other non-currentassets$5,841K (130.87%↑ Y/Y)Restricted cash$1,587K (0.19%↑ Y/Y)Total assets$311,153K (-19.28%↓ Y/Y)Total liabilities andstockholders equity$311,153K (-19.28%↓ Y/Y)Total stockholdersequity$233,815K (-21.78%↓ Y/Y)Total liabilities$77,338K (-10.62%↓ Y/Y)Accumulated deficit-$1,688,462K (-17.26%↓ Y/Y)Accumulated othercomprehensive (loss) income-$158K (-377.19%↓ Y/Y)Additional paid-in capital$1,922,433K (10.56%↑ Y/Y)Total currentliabilities$39,867K (8.03%↑ Y/Y)Operating leaseliabilities, non-current$36,934K (-20.74%↓ Y/Y)Other non-currentliabilities$537K (-82.28%↓ Y/Y)Common stock, 0.0001par value 500,000...$2K (100.00%↑ Y/Y)Accrued liabilities andother current...$35,988K (28.53%↑ Y/Y)Accounts payable$3,879K (14.80%↑ Y/Y)

Lyell Immunopharma, Inc. (LYEL)

Lyell Immunopharma, Inc. (LYEL)